Invomed Cotab Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 8.12 M
- Company Age 22 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.00 M
- Revenue Growth -21.69%
- Profit Growth -56.41%
- Ebitda 15.10%
- Net Worth 1.10%
- Total Assets -3.08%
About Invomed Cotab
Invomed Cotab Private Limited (ICPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 February 2003 and has a history of 22 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 8.12 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Divita Gulati and Sunil Gulati serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2003PTC040513
- Company No.
040513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Invomed Cotab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divita Gulati  | Director | 22-Oct-2004 | Current |
| Sunil Gulati | Director | 22-Oct-2004 | Current |
Financial Performance of Invomed Cotab.
Invomed Cotab Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 21.69% decrease. The company also saw a substantial fall in profitability, with a 56.41% decrease in profit. The company's net worth moved up by a moderate rise of 1.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invomed Cotab?
In 2021, Invomed Cotab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zesto Pharmaceuticals Private LimitedDivita Gulati is a mutual person
Charges (Loans)
₹0
₹8.00 M
Charges Breakdown by Lending Institutions
- A.P.S.F.C. : 0.60 Cr
- The Lakshmi Vilas Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Mar 2006 | The Lakshmi Vilas Bank Limited | ₹2.00 M | Satisfied |
| 17 Feb 1985 | A.P.S.F.C. | ₹6.00 M | Satisfied |
How Many Employees Work at Invomed Cotab?
Invomed Cotab has a workforce of 13 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invomed Cotab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invomed Cotab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.